DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

197.44 -1.85 (-0.93%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALXN $197.44 -0.93%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $200.00
Previous Close $199.29
Daily Range $196.32 - $200.00
52-Week Range $150.06 - $208.88
Market Cap $44.6B
P/E Ratio 68.25
Dividend (Yield) $0.00 (0.0%)
Volume 1,697,860
Average Daily Volume 2,087,108
Current FY EPS $5.29

Sector

Healthcare

Industry

Drug Makers

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary

How Rare-Disease Drugmaker Alexion Pharmaceuticals Found Its Groove in June

A trio of positive events sends rare disease-drug developer Alexion shooting higher by a double-digit percentage. Can the good times continue?

Alexion Pharmaceuticals (ALXN) Earnings Report: Q2 2015 Conference Call Transcript

Health Care Sector Update for 07/31/2015: ALXN, NLNK, UHS

Premarket Biotech Digest: Amgen Beats, GlaxoSmithKline Corruption Charges, VTv Therapeutics Flops On

Premarket Biotech Digest: Amgen Beats, GlaxoSmithKline Corruption Charges, VTv Therapeutics Flops On Debut

Alexion Misses on Earnings in Q2, 2015 Outlook Revised - Analyst Blog

Alexion Pharmaceuticals (ALXN) Stock Gained on Earnings as Guidance Lowered

3 Stocks Pushing The Drugs Industry Downward

Alexion (ALXN) Misses on Q2 Earnings, Revises Outlook - Tale of the Tape

Noteworthy ETF Outflows: RSP, CB, CELG, ALXN

Alexion Pharmaceuticals (ALXN) Q2 2015 Results - Earnings Call Webcast

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog

See More ALXN News...

ALXN's Top Competitors

ALXN $197.44 (-0.93%)
Current stock: ALXN
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB